SEC Form 4 · accession 0001209191-17-057875
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Aron Marc Knickerbocker
Officer — Chief Operating Officer · Director
Period of report
Oct 20, 2017
Accepted (ET)
Oct 24, 2017 · 5:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $46.80 | Oct 20, 2017 | A | 138,450 | A | — | Oct 19, 2027 | Common Stock | 138,450 | 138,450 | D |
Explanation of responses
- F1The shares underlying the option vest at a rate of one forty-eighth (1/48th) per month starting on November 20, 2017, provided the reporting person provides services to Five Prime Therapeutics, Inc. through each such date.